uman albumin 200g/l solution for infusion (50ml vial)
kedrion s.p.a loc. ai conti, 55051 castelvecchio pascoli, barga - lucca, italy - albumin, human - solution for infusion - albumin, human 20 g/100ml - blood substitutes and perfusion solutions
uman albumin 200g/l solution for infusion (100ml vial)
kedrion s.p.a loc. ai conti, 55051 castelvecchio pascoli, barga - lucca, italy - albumin, human - solution for infusion - albumin, human 20 g/100ml - blood substitutes and perfusion solutions
emoclot 1000iu/10ml, powder and solvent for solution and infusion + infusion set
kedrion s.p.a loc. ai conti, 55051 castelvecchio pascoli, barga - lucca, italy - factor viii, human - powder and solvent for solution for infusion - factor viii, human 1000 iu - antihemorrhagics
aimafix 500i.u. pow. for solu. for infu powder and solvent for solution for infusion
kedrion, italy - human plasma coagulation factor ix - powder and solvent for solution for infusion - 500 iu
uman albumin 20% solution for infusion
kedrion, italy - albumin human - solution - 20 %
uman albumin 20% solution for infusion
kedrion, italy - albumin human - solution - 20 %
uman albumin solution for infusion
kedrion s.p.a loc. ai conti - castelvecchio pascoli , 55051 - human albumin bulk solution - solution for infusion - 200g/l ( 20%) solution for infusion - albumin
aimafix 500i.u. pow. for solu. for infu powder and solvent for solution for infusion
kedrion, italy - human plasma coagulation factor ix - powder and solvent for solution for infusion - 500 iu
kedbumin (albumin- human injection, solution
kedrion s.p.a - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 12.5 g in 50 ml - for restoration and maintenance of circulating blood volume where volume deficiency is demonstrated and colloid use is appropriate. kedbumin® is indicated for severe albumin deficiency caused by illness or active bleeding. when albumin deficiency results from excessive protein loss, the effect of albumin administration will be temporary unless the underlying disorder is reversed. kedbumin® is indicated for maintenance of cardiovascular function following the removal of large volumes of ascitic fluid due to cirrhosis [1, 2]. kedbumin® is indicated as a plasma expander in the fluid management of severe forms of ovarian hyperstimulation syndrome (ohss) [3, 4]. kedbumin® is indicated in conjunction with diuretics to correct fluid volume overload associated with ards [5]. kedbumin® is indicated after > 24 hours post burn in patients experiencing severe albumin depletion in order to favor edema re-absorption [6]. kedbumin® is indicated in patients undergoing long term dialysis or for those patients who are fl
albuked (albumin- human solution
kedrion biopharma, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 10 g in 50 ml - emergency treatment of hypovolemic shock albuked 20 is hyperoncotic and on intravenous infusion will expand the plasma volume by an additional amount, three to four times the volume actually administered, by withdrawing fluid from the interstitial spaces, provided the patient is normally hydrated interstitially or there is interstitial edema.(1) if the patient is dehydrated, additional crystalloids must be given,(4) or alternatively, albumin (human) 5%, usp (albuked™ 5) should be used. the patient’s hemodynamic response should be monitored and the usual precautions against circulatory overload observed. the total dose should not exceed the level of albumin found in the normal individual; i.e., about 2 g per kg body weight in the absence of active bleeding. although albuked 5 is to be preferred for the usual volume deficits, albuked 20 with appropriate crystalloids may offer therapeutic advantages in oncotic deficits or in long-standing shock where treatment has been delayed.(2) removal of ascitic fluid from a